Inventor · disambiguated record
Petrus Jacobus Johannes Antonius Buijnsters
Also filed as: BUIJNSTERS PETRUS JACOBUS JOHANNES ANTONIUS
4 granted patents·6 pending applications·0 citations·filing 2016–2021
52Inventor score
Files withJANSSEN PHARMACEUTICA NV10
Top patents by PatentIndex Score
10 records- 0153US2024124487A1Branched macrocyclic 4-(pyrazol-5-yl)-indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0250US2023250109A1Macrocyclic ether containing indole derivatives as inhibitors of mcl-1JANSSEN PHARMACEUTICA NV·Filed 2021·Application pending·0 cites
- 0350US2023058733A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 0450US2023099293A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2020·Application pending·0 cites
- 0542US2021130352A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0642US2021277003A1Oga inhibitor compoundsJANSSEN PHARMACEUTICA NV·Filed 2019·Application pending·0 cites
- 0741US11053248B2[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jul 6, 2021·0 cites·9 claims
- 0841US10947239B2[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compoundJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Mar 16, 2021·0 cites·11 claims
- 0940US11319321B2[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted May 3, 2022·0 cites·6 claims
- 1036US10947242B2[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Mar 16, 2021·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Petrus Jacobus Johannes Antonius Buijnsters files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →